BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23967787)

  • 21. Pharmacologic and Non-Pharmacologic Dyspnea Management in Advanced Cancer Patients.
    Zemel RA
    Am J Hosp Palliat Care; 2022 Jul; 39(7):847-855. PubMed ID: 34510917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dying With Dyspnea in the Hospital.
    Morris D; Galicia-Castillo M
    Am J Hosp Palliat Care; 2017 Mar; 34(2):132-134. PubMed ID: 26341104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dyspnea in lung cancer].
    Bonnichon A; Le Floch H; Rivière F; Staub E; Mairovitz A; Marotel C; Vaylet F; Margery J
    Rev Pneumol Clin; 2008 Apr; 64(2):62-8. PubMed ID: 18589285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine for palliative sedation in the emergency department.
    Shlamovitz GZ; Elsayem A; Todd KH
    J Emerg Med; 2013 Feb; 44(2):355-7. PubMed ID: 23047198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world.
    Escalante CP; Martin CG; Elting LS; Cantor SB; Harle TS; Price KJ; Kish SK; Manzullo EF; Rubenstein EB
    Cancer; 1996 Sep; 78(6):1314-9. PubMed ID: 8826956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of moderate-to-severe dyspnea in hospitalized patients receiving palliative care.
    Gomutbutra P; O'Riordan DL; Pantilat SZ
    J Pain Symptom Manage; 2013 May; 45(5):885-91. PubMed ID: 22940561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives on care at the close of life. Management of dyspnea in patients with far-advanced lung disease: "once I lose it, it's kind of hard to catch it... ".
    Luce JM; Luce JA
    JAMA; 2001 Mar; 285(10):1331-7. PubMed ID: 11255389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyspnea: assessment and treatment.
    Farncombe M
    Support Care Cancer; 1997 Mar; 5(2):94-9. PubMed ID: 9069607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End of life issues.
    Sykes N
    Eur J Cancer; 2008 May; 44(8):1157-62. PubMed ID: 18374561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea.
    Ross DD; Alexander CS
    Am Fam Physician; 2001 Sep; 64(6):1019-26. PubMed ID: 11578023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of refractory breathlessness in patients with advanced disease].
    Bausewein C
    Internist (Berl); 2016 Oct; 57(10):978-982. PubMed ID: 27587195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short of breath and dying: state of the science on opioid agents for the palliation of refractory dyspnea in older adults.
    Lowey SE; Powers BA; Xue Y
    J Gerontol Nurs; 2013 Feb; 39(2):43-52. PubMed ID: 23244062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High flow nasal therapy in the management of hypoxemic dyspnea at the end of life.
    Mercadante S; Giuliana F
    Support Care Cancer; 2021 Nov; 29(11):6179-6181. PubMed ID: 33990883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient.
    Graff GR; Stark JM; Grueber R
    Respiration; 2004; 71(6):646-9. PubMed ID: 15627879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing dyspnea and cough.
    Dudgeon DJ
    Hematol Oncol Clin North Am; 2002 Jun; 16(3):557-77, viii. PubMed ID: 12170568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palliative Care Physicians' Practice in the Titration of Parenteral Opioids for Dyspnea in Terminally Ill Cancer Patients: A Nationwide Survey.
    Mori M; Matsunuma R; Suzuki K; Matsuda Y; Watanabe H; Yamaguchi T
    J Pain Symptom Manage; 2019 Jul; 58(1):e2-e5. PubMed ID: 30999067
    [No Abstract]   [Full Text] [Related]  

  • 37. Oncologic Emergencies: Palliative Care in the Emergency Department Setting.
    Long DA; Koyfman A; Long B
    J Emerg Med; 2021 Feb; 60(2):175-191. PubMed ID: 33092975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study.
    Clemens KE; Quednau I; Klaschik E
    Support Care Cancer; 2009 Apr; 17(4):367-77. PubMed ID: 18719948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro re nata prescribing in a population receiving palliative care: a prospective consecutive case note review.
    Russell BJ; Rowett D; Currow DC
    J Am Geriatr Soc; 2014 Sep; 62(9):1736-40. PubMed ID: 25124943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyspnea: the continuing challenge of palliative management.
    LeGrand SB
    Curr Opin Oncol; 2002 Jul; 14(4):394-8. PubMed ID: 12130922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.